Clinical Trial: Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Ovary Cancer
Study Type: INTERVENTIONAL
Official Title: The Impact of Alternate Day Fasting After Surgery for Patients Undergoing chemoTherapy (FAST Study)
Brief Summary:
Endometrial cancer is the most common gynecologic cancer and ovarian cancer is the most lethal.The management of both advanced cancers is a combination of chemotherapy and surgery.Standard of care chemotherapeutic treatment for uterine and ovarian cancers is toxic and severely disruptive to the patient's quality of life with the potential for devastating short and long-term side effects.The role of fasting and ketogenic diets has been evaluated in a mixed cancer population and previously shown to be…
Read more